110233 ⎘
Reverse transcribing DNA viruses; Details; Hepadnaviridae; Orthohepadnavirus, e.g. hepatitis B virus; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID
#2GENETIC THERAPY FOR GLAUCOMA AND OPTIC NEUROPATHIES
#3COMPOSITION FOR TREATING HEPATITIS B, AND METHOD FOR EVALUATING REPLICATION ACTIVITY OF HEPATITIS B VIRUS
#4COMPOSITIONS AND METHODS FOR TREATING NEUROCOGNITIVE DISORDERS
#5COMPOSITIONS AND METHODS FOR TREATING NEUROCOGNITIVE DISORDERS
#6GENE THERAPY FOR PATIENTS WITH FANCONI ANEMIA
#7Tumor vaccination involving a humoral immune response against self-proteins
#8Virus like vesicles (VLVS) based vaccines to prevent or treat chronic hepatitis B virus (HBV) infection
#9Vaccines for protection from and treatment of alzheimer's disease
#10Methods and compositions for increasing transgene activity
#11DNA vaccine containing specific epitope of apolipoprotein (a)
#12USE OF MEGANUCELASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF
#13Rodent hepadnavirus cores with reduced carrier-specific antigenicity
#14DNA vaccine containing VEGF-specific epitope and/or angiopoietin-2-specific epitope
#15Tumor vaccination involving a humoral immune response against self-proteins
#16Vaccines for protection from and treatment of alzheimer's disease
#17DNA vaccine
#18Tumor vaccination involving a humoral immune response against self-proteins
#19USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF
#20USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF
#21Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
#22USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF
#23USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF
#24USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF
#25Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
#26CUSTOM-MADE MEGANUCLEASE AND USE THEREOF
#27Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
#28USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF
#29Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
#30VACCINE DELIVERY SYSTEM
#31Custom-made meganuclease and use thereof
#32Method for gene transfer into the organelles of cells: direct gene transfer to mitochondria
#33Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
#34Method of protein production using mitochondrial translation system
#35Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the same
#36Methods and compositions for expressing heterologous genes in hepatocytes using hepadnaviral vectors
#37Composition for regulating production of interfering ribonucleic acid
#38Composition for regulating production of interfering ribonucleic acid
#39Composition for regulating production of interfering ribonucleic acid